Develops ultra-stable antibody-drug conjugates for solid tumors with the P5 platform.
Founders
Dominik Schumacher(Germany · ♂)— A chemical biologist and MIT Innovator Under 35 who spun his academic work on protein conjugation out of FMP and LMU to co-found Tubulis in 2018 building next-generation antibody-drug conjugates.
Jonas Helma-Smets(Germany · ♂)— An antibody-engineering scientist who co-founded Tubulis and serves as Chief Scientific Officer, bringing over a decade of biotech and conjugation expertise.
Christian Hackenberger(Germany · ♂)— An FMP professor whose protein-chemistry research underpinned Tubulis's conjugation platform, co-founding the company as a scientific founder.
Heinrich Leonhardt(Germany · ♂)— An LMU molecular-biology professor whose lab work seeded Tubulis's technology, co-founding the ADC company in 2018.
Ingo Lehrke CBO at Tubulis & CEO at AlgiaxJonas Helma-Smets CSO and co-founder at Tubulis GmbHBjoern M Hock Founder and CEO, Lavaux Biotech consulting; CDO Tubulis GmbHChristian Groendahl Co-founder and CEO SNIPR BIOME, Chairman of the Supervisory Board Tubulis GmbH
Members see the full profile
Create a free EquityFlow account to see Tubulis's 1 funding round, 3 investors, 12 similar companies.